Assessment of Drug Interactions Between Antiretroviral and the Anthelminthic drugs

Autor: Kigen, Gabriel Kimutai

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.507508

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Autor: Busakhala NW; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Waako PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Strother MR; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Keter AK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Kigen GK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Asirwa FC; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN., Loehrer PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and University of Otago, Christchurch, New Zealand; Fredrick Chite Asirwa, Indiana University Simon Cancer Center, Indianapolis, IN.

Publikováno v: Journal of global oncology [J Glob Oncol] 2018 Sep; Vol. 4, pp. 1-9.